Loading provider…
Loading provider…
Hematology & Oncology Physician in Indianapolis, IN
NPI: 1063477073Primary Practice Location
INDIANA UNIVERSITY HEALTH
1701 N Senate Blvd, Indianapolis, IN
Primary Employer
IU Health Medical Group, LLC
iuhealth.org
HQ Phone
Get MD Anne's Phone Numberphone_androidMobile
Get MD Anne's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIN State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 174 | 228 |
| 2 | 36415Insertion of needle into vein for collection of blood sample | 95 | 183 |
| 3 | 99212Established patient outpatient visit, total time 10-19 minutes | 85 | 122 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 22 | 28 |
| 5 | 96365Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | 14 | 24 |
Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US).
Authors: Amy Shapiro
Publication Date: 2011-02-18
Authors: Magdalena Lewandowska, Nicole Randall, Nihal Bakeer, Amy Shapiro
Journal: Haemophilia
Publication Date: 2020-11-27
Lead Sponsor: Lifespan
Collaborators: Doris Duke Charitable Foundation
Intervention / Treatment: DRUG: Hydroxyurea
Lead Sponsor: Indiana Hemophilia &Thrombosis Center, Inc.
Collaborators: Genentech, Inc.
Intervention / Treatment: DRUG: Emicizumab
Lead Sponsor: Indiana Hemophilia &Thrombosis Center, Inc.
Collaborators: Genentech, Inc.
Intervention / Treatment: DRUG: Emicizumab